Like
Share
멍실장
종양 마커 검사 종류와 의미

What Are Pet Tumor Marker Tests? — From Types to Result Interpretation

ImmunityQ&AMeongsiljang Veterinary Advisory Board

Tumor marker tests are supplementary exams that measure cancer-related substances in blood or tissue to help with cancer diagnosis and monitoring disease progression. Here’s a summary of the different types and how to interpret the results.

What Are Tumor Marker Tests?

A scene of a veterinarian collecting a blood sample from a dog at the animal hospital.
Tumor marker tests are supplementary examinations that measure specific substances produced by cancer cells or secreted by the body in response to cancer, detected in blood, urine, or tissue samples. They are not standalone diagnostic tests for confirming cancer. They are primarily used to complement imaging and tissue biopsies to detect suspected cancer at an early stage or to monitor for recurrence and metastasis after treatment. Their utility as an auxiliary indicator is increasingly growing in health screenings for senior dogs and cats at high risk.

Why Perform Tumor Marker Tests?

Pets often show few early signs of cancer, so by the time owners notice something’s wrong, the disease has frequently progressed significantly. Tumor markers help catch these early hints of hidden cancer. For pets already diagnosed with cancer, regularly monitoring marker levels after surgery or chemotherapy can also help detect recurrence or metastasis sooner. Veterinary internal medicine textbooks emphasize that tumor markers must always be interpreted alongside imaging and histopathology.

Common Types of Tumor Markers

In veterinary clinical practice, commonly used biomarkers are broadly categorized into blood-based markers and tissue-based markers. Blood markers can be included in routine health screenings, while tissue markers are measured by pathology laboratories using samples obtained through biopsy. The table below provides a clear comparison of representative markers.

Comparison of Major Tumor Markers

ItemSpecimenCancers mainly assessed
TK1 (thymidine kinase 1)BloodHematologic cancers such as lymphoma · leukemia (adjunct)
CRP (C-reactive protein)BloodInflammation · some solid tumors (nonspecific)
V-BTA (bladder tumor antigen)UrineBladder transitional cell carcinoma (beware false positives)
Ki67Tissue (biopsy)Grading of mast cell tumors · lymphoma
AgNORTissue (biopsy)Assessment of cell proliferation rate
Mitotic index (MI)Tissue (biopsy)Mast cell tumor grading · prognosis prediction
PCR clonality testTissue · bloodAdjunct for confirming lymphoma

Interpretation of values is always done by a veterinarian together with imaging and tissue tests.

Blood Markers: TK1 and CRP

TK1 (thymidine kinase 1) is an enzyme that increases when cells divide, so its levels tend to rise in blood cancers such as lymphoma. If TK1 levels are high during a health checkup, further imaging and tissue biopsies are typically recommended. CRP is an inflammatory marker that can be elevated not only in cancer but also in infections and arthritis, so it cannot be used alone to diagnose cancer. However, it can be helpful for monitoring treatment progress or assessing the degree of systemic inflammation.
A veterinarian explaining the blood test results.

Tissue Markers: Ki67 and AgNOR

According to veterinary dermatology textbooks, after surgically removing a mass such as a mast cell tumor, its malignancy (grade) is assessed using histological markers like Ki67 and AgNOR. Ki67 is a nuclear protein absent in resting (G0) cells and expressed only in cells actively participating in the cell cycle; therefore, a higher number of Ki67-positive cells indicates more vigorous cellular proliferation. AgNOR staining highlights specific regions within the nucleus with silver, revealing how frequently cells are dividing. Furthermore, the mitotic index (MI) is directly correlated with tumor grade and is considered the most reliable prognostic indicator. In mast cell tumors, an MI exceeding 5–7 suggests a high likelihood of a poor prognosis. These proliferation markers all provide crucial insights for determining prognosis and deciding on additional treatment.

When to Consider Tumor Marker Testing

It is recommended as a supplementary indicator in routine health screenings for senior pets aged seven and older, for monitoring recurrence or metastasis in pets currently undergoing cancer treatment or post-surgery, and when unexplained weight loss, anemia, or loss of appetite persists for more than two weeks. However, please do not become anxious based on a single value; always have the results interpreted by a veterinarian.

Limitations of Tumor Marker Tests

Tumor markers are not a universal cancer screening tool. A normal result does not rule out cancer (false negative), and elevated levels can also occur due to other conditions such as inflammation, infection, or liver disease (false positive). In particular, there are fewer clinically validated tumor markers for cats than for dogs. Therefore, veterinary internal medicine textbooks emphasize that tumor markers should never be used for standalone diagnosis and must always be interpreted in conjunction with imaging, cytology, and histopathology.
A cat undergoing an ultrasound examination

Test Costs and Preparation Process

Tumor marker testing costs vary significantly depending on whether a clinic offers the test in-house or sends it out to an external laboratory. Generally, blood-based tumor markers are more expensive than routine blood work but less costly than standalone CT or MRI scans. Preparation is similar to that for standard blood tests, with an 8- to 12-hour fast often recommended. For tissue-based markers, the test is performed on tumor tissue that has already been surgically removed, so no additional anesthesia is required. Please consult your veterinarian for exact costs and preparation instructions.

Reviewed by a veterinarian

Dr. Tony — Punnawat Phongkittirak

Dr. Tony — Punnawat Phongkittirak

Veterinarian

A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.

Frequently Asked Questions

Can a tumor marker test alone definitively confirm whether my pet has cancer?
No, tumor markers are only supportive tests and cannot confirm a diagnosis on their own. If the results are suspicious, further evaluation with ultrasound, CT, or a biopsy is necessary.
Should healthy pets receive regular check-ups too?
It’s not mandatory. However, for senior pets or those at higher risk of tumors due to breed or family history, it can be considered as an additional indicator during regular health check-ups. The specific tests and frequency should be determined in consultation with your veterinarian based on your pet’s individual condition.
My TK1 levels came back high. Does that mean my pet has cancer?
Not necessarily. Levels can also rise in cases of acute infection or inflammation, so it’s important to monitor trends through imaging tests and follow-up blood work.
Can the same tumor markers used in dogs be used in cats?
While there is some overlap, the number of markers that have been specifically validated and commercialized for cats remains limited. As a result, imaging and cytology play a more significant role in feline diagnostics.
How often should follow-up checks be done to monitor for recurrence after surgery?
The follow-up schedule varies significantly depending on the type and stage of cancer. Typically, we monitor for recurrence and metastasis by tracking tumor marker levels alongside imaging studies at regular intervals after surgery and treatment. Your veterinarian will determine the precise frequency of these check-ups based on your pet’s individual condition.

Share

Related Guides

References

[1] BSAVA Manual of Canine and Feline Dermatology, 4th Edition — Proliferation markers for tumours (Ki67, AgNOR)

[2] The Cat, Clinical Medicine and Management, 2nd Edition — Histologic markers in feline mammary tumors

[3] Veterinary Surgical Oncology, 2nd Edition — Prognostic molecular variables in canine tumors

[4] Withrow & MacEwen's Small Animal Clinical Oncology, 6th Edition — Tumor markers and paraneoplastic syndromes

This information is based on veterinary literature and does not replace diagnosis or treatment. Please consult a veterinarian for specific health concerns.

Metapet Co., Ltd. | CEO: Park Sung-yong | Business Reg. No. 417-88-02562 | Seoul, South Korea | Customer Center

What Is a Pet Tumor Marker Test? Types and How to Interpret Results | Meongsiljang